期刊
ONCOTARGET
卷 7, 期 46, 页码 76062-76075出版社
IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.12584
关键词
oral cancer; Gli2; hedgehog; TGF-B; parathroid hormone related protein (PTHrP)
资金
- NIH [CA163499]
- VA Merit Award [1I01BX001957]
- DOD [W81XWH-15-1-0622]
- VICTR Funding (CTSA Award) [UL1TR000445, VR16993]
- Initiative to Maximize Student Diversity Award [2R25GM062459]
- [1S10RR027027631]
Oral Squamous Cell Carcinoma (OSCC) is the sixth most common cancer worldwide. OSCC invasion into the lymph nodes and mandible correlates with increased rates of recurrence and lower overall survival. Tumors that infiltrate mandibular bone proliferate rapidly and induce bone destruction. While survival rates have increased 12% over the last 20 years, this improvement is attributed to general advances in prevention, earlier detection, and updated treatments. Additionally, despite decades of research, the molecular mechanisms of OSCC invasion into the mandible are not well understood. Parathyroid Hormone-related Protein (PTHrP), has been shown to be essential for mandibular invasion in OSCC animal models, and our previous studies demonstrate that the transcription factor Gli2 increases PTHrP expression in tumor metastasis to bone. In OSCC, we investigated regulators of Gli2, including Hedgehog, TGF beta, and Wnt signaling to elucidate how PTHrP expression is controlled. Here we show that canonical Hedgehog and TGF beta signaling cooperate to increase PTHrP expression and mandibular invasion in a Gli2-dependent manner. Additionally, in an orthotopic model of mandibular invasion, inhibition of Gli2 using shRNA resulted in a significant decrease of both PTHrP expression and bony invasion. Collectively, our findings demonstrate that multiple signaling pathways converge on Gli2 to mediate PTHrP expression and bony invasion, highlighting Gli2 as a therapeutic target to prevent bony invasion in OSCC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据